Compound details
Scopanolal
| Compound ID | CDAMM01268 |
|---|---|
| Common name | Scopanolal | IUPAC name | [8-(hydroxymethyl)-4a,8-dimethyl-3-methylidene-4-(3-methyl-5-oxopent-3-enyl)-2,4,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] benzoate |
| Molecular formula | C27H36O4 |
| Retention time | 12.64 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 425.273 | Theoretical mz | 425.268 |
| Error | 11.34 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.5777 |
| Inchi key | IQFDAOLIRBRVJU-DAIPCRNUNA-N |
|---|---|
| Smiles | O=CC=C(C)CCC1C(=C)CC(OC(=O)C=2C=CC=CC2)C3C(C)(CO)CCCC13C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SwissTargetPrediction |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SwissTargetPrediction |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | T19244 | SwissTargetPrediction |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | T37848 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P11940 | PABPC1 | Polyadenylate-binding protein 1 | T58679 | SwissTargetPrediction |
| Q16739 | UGCG | Ceramide glucosyltransferase | T14908 | SwissTargetPrediction |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SwissTargetPrediction |
| P42785 | PRCP | Lysosomal Pro-X carboxypeptidase | T20371 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P53985 | SLC16A1 | Monocarboxylate transporter 1 (by homology) | T95842 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SwissTargetPrediction |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P49327 | FASN | Fatty acid synthase | T16514 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| P32245 | MC4R | Melanocortin receptor 4 | T72458 | SwissTargetPrediction |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| Q16850 | CYP51A1 | Cytochrome P450 51 (by homology) | T32972 | SwissTargetPrediction |
| P11387 | TOP1 | DNA topoisomerase I | T09826 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| Q15858 | SCN9A | Sodium channel protein type IX alpha subunit | T12119 | SwissTargetPrediction |
| P36897 | TGFBR1 | TGF-beta receptor type I | T53389 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor | T15439 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| Q99835 | SMO | Smoothened homolog | T66505 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| P27815 | PDE4A | Phosphodiesterase 4A | T61744 | SwissTargetPrediction |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| Q16584 | MAP3K11 | Mitogen-activated protein kinase kinase kinase 11 | T12126 | SwissTargetPrediction |
| P80192 | MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | T19760 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| O14649 | KCNK3 | Potassium channel subfamily K member 3 | T15795 | SwissTargetPrediction |
| O60760 | HPGDS | Hematopoietic prostaglandin D synthase | T19433 | SwissTargetPrediction |
| P25116 | F2R | Proteinase-activated receptor 1 | T36483 | SwissTargetPrediction |
| P21452 | TACR2 | Neurokinin 2 receptor | T52790 | SwissTargetPrediction |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SwissTargetPrediction |
| Q9GZN0 | GPR88 | Probable G-protein coupled receptor 88 | T37505 | SwissTargetPrediction |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SwissTargetPrediction |
| P10415 | BCL2 | Apoptosis regulator Bcl-2 | T31309 | SwissTargetPrediction |
| Q16665 | HIF1A | Hypoxia-inducible factor 1 alpha | T55610 | SwissTargetPrediction |
| Q12866 | MERTK | Proto-oncogene tyrosine-protein kinase MER | T55781 | SwissTargetPrediction |
| Q00796 | SORD | Sorbitol dehydrogenase | T59445 | SwissTargetPrediction |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | T94880 | SwissTargetPrediction |
| Q08493 | PDE4C | Phosphodiesterase 4C | T12081 | SwissTargetPrediction |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SwissTargetPrediction |
| Q9NRG4 | SMYD2 | N-lysine methyltransferase SMYD2 | T15797 | SwissTargetPrediction |
| P55055 | NR1H2 | LXR-beta | T13714 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q00975 | CACNA1B | Voltage-gated N-type calcium channel alpha-1B subunit | T38338 | SwissTargetPrediction |
| P37173 | TGFBR2 | TGF-beta receptor type II | T49989 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T19244 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11712 | CYP2C9 |
| T37848 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08684 | CYP3A4 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T58679 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11940 | PABPC1 |
| T14908 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | Q16739 | UGCG |
| T14908 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | Q16739 | UGCG |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T16514 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P49327 | FASN |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T72458 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | P32245 | MC4R |
| T72458 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P32245 | MC4R |
| T72458 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P32245 | MC4R |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T32972 | DI0209 | Infectious meningitis | [ICD-11: 1D01] | Q16850 | CYP51A1 |
| T32972 | DI0289 | Nail/perionychium infection | [ICD-11: EE12] | Q16850 | CYP51A1 |
| T32972 | DI0316 | Onchocerciasis | [ICD-11: 1F6A] | Q16850 | CYP51A1 |
| T09826 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11387 | TOP1 |
| T09826 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11387 | TOP1 |
| T09826 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11387 | TOP1 |
| T09826 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P11387 | TOP1 |
| T09826 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11387 | TOP1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T12119 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q15858 | SCN9A |
| T12119 | DI0087 | Chronic pain | [ICD-11: MG30] | Q15858 | SCN9A |
| T12119 | DI0140 | Extremities vasodilatation | [ICD-11: EG00] | Q15858 | SCN9A |
| T12119 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q15858 | SCN9A |
| T12119 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q15858 | SCN9A |
| T12119 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q15858 | SCN9A |
| T12119 | DI0358 | Radiculopathy | [ICD-11: 8B93] | Q15858 | SCN9A |
| T12119 | DI0415 | Trigeminal nerve disorder | [ICD-11: 8B82] | Q15858 | SCN9A |
| T53389 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P36897 | TGFBR1 |
| T53389 | DI0238 | Lung cancer | [ICD-11: 2C25] | P36897 | TGFBR1 |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T15439 | DI0431 | Vasculitis | [ICD-11: 4A44] | P21730 | C5AR1 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T66505 | DI0047 | Basal cell carcinoma | [ICD-11: 2C32] | Q99835 | SMO |
| T66505 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | Q99835 | SMO |
| T66505 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99835 | SMO |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T61744 | DI0037 | Asthma | [ICD-11: CA23] | P27815 | PDE4A |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T19760 | DI0037 | Asthma | [ICD-11: CA23] | P80192 | MAP3K9 |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T15795 | DI0309 | Obstructive sleep apnoea | [ICD-11: 7A41] | O14649 | KCNK3 |
| T19433 | DI0148 | Flatworm infection | [ICD-11: 1F70-1F86] | O60760 | HPGDS |
| T36483 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P25116 | F2R |
| T52790 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P21452 | TACR2 |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T31309 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10415 | BCL2 |
| T31309 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P10415 | BCL2 |
| T31309 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | P10415 | BCL2 |
| T31309 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10415 | BCL2 |
| T55610 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q16665 | HIF1A |
| T55610 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16665 | HIF1A |
| T55781 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q12866 | MERTK |
| T55781 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q12866 | MERTK |
| T55781 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q12866 | MERTK |
| T55781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q12866 | MERTK |
| T94880 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06418 | TYRO3 |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T15797 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9NRG4 | SMYD2 |
| T15797 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRG4 | SMYD2 |
| T13714 | DI0039 | Atopic eczema | [ICD-11: EA80] | P55055 | NR1H2 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T38338 | DI0264 | Migraine | [ICD-11: 8A80] | Q00975 | CACNA1B |
| T38338 | DI0305 | Non-thrombocytopenic purpura | [ICD-11: 3B60] | Q00975 | CACNA1B |
| T38338 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q00975 | CACNA1B |
| T49989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P37173 | TGFBR2 |